Free Trial

Eloxx Pharmaceuticals (ELOX) SEC Filings & 10K Form

Eloxx Pharmaceuticals logo

Recent Eloxx Pharmaceuticals SEC Filings

DateFilerForm TypeView
02/21/2025
9:00 AM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form SEC STAFF ACTION
01/28/2025
4:35 PM
Androski Lindsay (Reporting)
Eloxx Pharmaceuticals, Inc. (Issuer)
Eloxx Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
4:36 PM
Eloxx Pharmaceuticals, Inc. (Issuer)
Eloxx Pharmaceuticals (Issuer)
Rubin Steven D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
4:37 PM
Aggarwal Sumit (Reporting)
Eloxx Pharmaceuticals, Inc. (Issuer)
Eloxx Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
4:34 PM
Eloxx Pharmaceuticals, Inc. (Issuer)
Eloxx Pharmaceuticals (Issuer)
Walts Alan Edmund (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
7:13 PM
Advent Life Sciences LLP (Filed by)
Eloxx Pharmaceuticals, Inc. (Subject)
Eloxx Pharmaceuticals (Subject)
Form SC 13D/A
07/16/2024
4:23 PM
Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:ELOX) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners